How Gut Dysfunction Drives Inflammation #shorts
20 Apr 2026 · 1 min

1:14
In this short, the speaker explains how patients with Hashimoto's thyroiditis often experience a gut‑related inflammatory cycle. Overgrowth of certain harmful bacteria in the gut produces lipopolysaccharide (LPS), which fuels systemic inflammation. This inflammation drives higher insulin and cortisol levels, which in turn keep thyroid peroxidase (TPO) antibodies elevated. Because of this ongoing inflammation, simply increasing thyroid hormone (T3) doses—such as high‑dose T3 or compounded thyroid medication—may improve lab values but often fails to make patients feel fully better. The speaker emphasizes that clinicians need to address gut inflammation and actively monitor TPO antibody trends to achieve true symptom relief.










